-+ 0.00%
-+ 0.00%
-+ 0.00%

Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan

PUBT·08/13/2026 20:19:53
Listen to the news
Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan
  • Ocular Therapeutix granted inducement equity awards to Beth Rada, its new SVP, Government Affairs and Public Policy.
  • Package includes a non-statutory stock option for 85,000 shares, priced at $9.24, effective Aug. 10, 2026.
  • Grant also includes restricted stock units covering 28,000 shares.
  • Stock option vests over four years, with 25% vesting after one year then monthly; term is 10 years.
  • RSUs vest over three years in equal annual installments, contingent on continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.